ORIENTBIO Inc. (002630) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

Based on the latest financial reports, ORIENTBIO Inc. (002630) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.77 Billion ≈ $1.20 Million USD) by net assets (₩67.73 Billion ≈ $45.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ORIENTBIO Inc. net asset quality index to measure how much of total assets are equity-financed.

ORIENTBIO Inc. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ORIENTBIO Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of ORIENTBIO Inc. to evaluate the quality of earnings relative to operating cash generation.

ORIENTBIO Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORIENTBIO Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Unitech Electronics Co. Ltd. TW:3652	-0.005x
Ribbon Acquisition Corp Unit NASDAQ:RIBBU	-0.001x
International Media Acquisition Corp NASDAQ:IMAQ	0.023x
Simply Better Brands Corp V:SBBC	-0.789x
Lake Resources N.L. AU:LKE	-0.064x
Snowman Logistics Limited NSE:SNOWMAN	0.109x
Ipopema Securities SA WAR:IPE	-3.010x
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd KQ:307750	0.040x

Annual Cash Flow Conversion Efficiency for ORIENTBIO Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see ORIENTBIO Inc. market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	₩71.85 Billion ≈ $48.69 Million	₩752.29 Million ≈ $509.82K	0.010x	-76.28%
2024-03-31	₩85.10 Billion ≈ $57.67 Million	₩3.76 Billion ≈ $2.55 Million	0.044x	+171.70%
2023-03-31	₩71.39 Billion ≈ $48.38 Million	₩1.16 Billion ≈ $786.07K	0.016x	-42.52%
2022-03-31	₩83.19 Billion ≈ $56.38 Million	₩2.35 Billion ≈ $1.59 Million	0.028x	-84.30%
2021-03-31	₩48.55 Billion ≈ $32.90 Million	₩8.74 Billion ≈ $5.92 Million	0.180x	+339.61%
2020-03-31	₩51.96 Billion ≈ $35.21 Million	₩-3.90 Billion ≈ $-2.65 Million	-0.075x	+59.21%
2019-03-31	₩62.65 Billion ≈ $42.45 Million	₩-11.54 Billion ≈ $-7.82 Million	-0.184x	-648.68%
2018-03-31	₩79.92 Billion ≈ $54.16 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.025x	+52.82%
2017-03-31	₩97.94 Billion ≈ $66.38 Million	₩-5.11 Billion ≈ $-3.46 Million	-0.052x	-621.81%
2016-03-31	₩91.29 Billion ≈ $61.87 Million	₩912.43 Million ≈ $618.34K	0.010x	-58.01%
2015-03-31	₩67.35 Billion ≈ $45.64 Million	₩1.60 Billion ≈ $1.09 Million	0.024x	-32.14%
2014-03-31	₩61.85 Billion ≈ $41.91 Million	₩2.17 Billion ≈ $1.47 Million	0.035x	-57.12%
2013-03-31	₩62.29 Billion ≈ $42.21 Million	₩5.09 Billion ≈ $3.45 Million	0.082x	+71.95%
2011-03-31	₩65.49 Billion ≈ $44.38 Million	₩3.11 Billion ≈ $2.11 Million	0.048x	-68.59%
2010-03-31	₩61.77 Billion ≈ $41.86 Million	₩9.35 Billion ≈ $6.34 Million	0.151x	+347.50%
2007-03-31	₩44.86 Billion ≈ $30.40 Million	₩1.52 Billion ≈ $1.03 Million	0.034x	--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$69.59 Million

₩102.69 Billion KRW

Market Cap Rank

#20559 Global

#1100 in Korea

Share Price

₩866.00

Change (1 day)

-2.70%

52-Week Range

₩467.00 - ₩1060.00

All Time High

₩6770.89